View Swift Biosciences Corporate Workshops from AMP 2016

Ann Arbor, MI, December 7, 2016 – Swift Biosciences held two highly regarded Corporate Workshops at the AMP 2016 Annual Meeting (Nov 9, 2016, Charlotte, NC) highlighting the use of NGS technologies for FFPE and liquid biopsy samples. Industry-leading speakers presented on Swift’s behalf. View [...]

December 7th, 2016|

Swift Biosciences and Fluxion Biosciences Announce Jointly Developed NGS Workflow for Somatic Mutation Detection from Liquid Biopsy Samples

South San Francisco, CA and Ann Arbor, MI, October 27, 2016 – In advance of the 2016 American Molecular Pathology (AMP) meeting, Swift Biosciences, Inc. and Fluxion Biosciences, Inc. announced a key advancement in cancer sequencing—improving the sensitivity to detect mutations at very low [...]

October 27th, 2016|

Menarini-Silicon Biosystems and Swift Biosciences Announce Collaboration to Offer Customized NGS Technologies for Tumor Cell Analysis

Products Optimized for Targeted Resequencing and Exome Sequencing of FFPE Cells BOLOGNA, Italy, October 25, 2016 – Menarini-Silicon Biosystems Inc., a developer and manufacturer of technologies and products that help uncover the biological complexities of dis­ease at the single-cell level, and Swift Biosciences, Inc., [...]

October 25th, 2016|